LFMDLifeMD, Inc.

$200M

Q2 2020 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$9M+236.9% YoY

Gross Profit

$7M75.9% margin

Operating Income

-$3M-35.4% margin

Net Income

-$3M-37.2% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

+111.2%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$438,575

Balance Sheet

Total Assets

$3M

Total Liabilities

$8M

Stockholders' Equity

-$4M

Cash & Equivalents

$336,151

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$3M	+236.9%
Gross Profit	$7M	$2M	+237.7%
Operating Income	-$3M	-$833,165	-286.3%
Net Income	-$3M	-$818,104	-313.0%

Revenue Segments

Product Revenues, Net

$8M87%

Software Revenues, Net

$1M13%

LFMD Q2 2020 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena